These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10805584)

  • 1. A new antimitotic substance, FR182877. II. The mechanism of action.
    Sato B; Nakajima H; Hori Y; Hino M; Hashimoto S; Terano H
    J Antibiot (Tokyo); 2000 Feb; 53(2):204-6. PubMed ID: 10805584
    [No Abstract]   [Full Text] [Related]  

  • 2. A new antimitotic substance, FR182877. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
    Sato B; Muramatsu H; Miyauchi M; Hori Y; Takase S; Hino M; Hashimoto S; Terano H
    J Antibiot (Tokyo); 2000 Feb; 53(2):123-30. PubMed ID: 10805571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
    Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis.
    de Arruda M; Cocchiaro CA; Nelson CM; Grinnell CM; Janssen B; Haupt A; Barlozzari T
    Cancer Res; 1995 Jul; 55(14):3085-92. PubMed ID: 7606731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new antimitotic substance, FR182877. III. Structure determination.
    Yoshimura S; Sato B; Kinoshita T; Takase S; Terano H
    J Antibiot (Tokyo); 2000 Jun; 53(6):615-22. PubMed ID: 10966078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric and highly stereoselective synthesis of the DEF-ring moiety of (-)-FR182877 and its derivative inducing mitotic arrest.
    Kobayakawa Y; Mori Y; Okajima H; Terada Y; Nakada M
    Org Lett; 2012 Apr; 14(8):2086-9. PubMed ID: 22462397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.
    Hood KA; West LM; Rouwé B; Northcote PT; Berridge MV; Wakefield SJ; Miller JH
    Cancer Res; 2002 Jun; 62(12):3356-60. PubMed ID: 12067973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI 980, and by its chiral isomer, NSC 613863.
    de Ines C; Leynadier D; Barasoain I; Peyrot V; Garcia P; Briand C; Rener GA; Temple C
    Cancer Res; 1994 Jan; 54(1):75-84. PubMed ID: 8261466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
    Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclin A kinase activity in E2F-1 chemogene therapy of colon cancer.
    Elliott MJ; Baker JD; Dong YB; Yang HL; Gleason JF; McMasters KM
    Tumour Biol; 2002; 23(6):324-36. PubMed ID: 12677090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells.
    Villa R; Zaffaroni N; Orlandi L; Bearzatto A; Costa A; Silvestrini R
    Eur J Cancer; 1994; 30A(10):1534-40. PubMed ID: 7833114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of bile carboxamide derivatives with pro-apoptotic effect on human colon adenocarcinoma cell lines.
    Brossard D; Lechevrel M; El Kihel L; Quesnelle C; Khalid M; Moslemi S; Reimund JM
    Eur J Med Chem; 2014 Oct; 86():279-90. PubMed ID: 25173827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
    Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
    Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells.
    Wu S; Guo Z; Hopkins CD; Wei N; Chu E; Wipf P; Schmitz JC
    Oncotarget; 2015 Dec; 6(38):40866-79. PubMed ID: 26506423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubulozole-induced G2/M cell cycle arrest in human colon cancer cells through formation of microtubule polymerization mediated by ERK1/2 and Chk1 kinase activation.
    Chou YH; Ho YS; Wu CC; Chai CY; Chen SC; Lee CH; Tsai PS; Wu CH
    Food Chem Toxicol; 2007 Aug; 45(8):1356-67. PubMed ID: 17329004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation.
    Mohan R; Banerjee M; Ray A; Manna T; Wilson L; Owa T; Bhattacharyya B; Panda D
    Biochemistry; 2006 May; 45(17):5440-9. PubMed ID: 16634625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).
    Capolongo L; Melegaro G; Broggini M; Mongelli N; Grandi M
    Br J Cancer; 1993 Nov; 68(5):916-9. PubMed ID: 8105866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
    Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
    Zeghari-Squalli N; Raymond E; Cvitkovic E; Goldwasser F
    Clin Cancer Res; 1999 May; 5(5):1189-96. PubMed ID: 10353756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The arotinoid Ro 40-8757 has antiproliferative effects in drug-resistant human colon and breast cancer cell lines in vitro.
    Louvet C; Empereur S; Fagot D; Forgue-Lafitte E; Chastre E; Zimber A; Mester J; Gespach C
    Cancer Lett; 1994 Sep; 85(1):83-6. PubMed ID: 7923106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.